Vertex Pharmaceuticals Incorporated (VRTX) has a market capitalization of $112.86B and trades at $444.28. The 52-week range is 362.5-510.77.
Key metrics include a trailing Price-to-Earnings (P/E) ratio of 28.7, Earnings Per Share (EPS) of $15.46, annual revenue of $12.07B.
The stock has a beta of 0.37, operates in the Healthcare sector.
